Scheffold, Annika
Stilgenbauer, Stephan
Funding for this research was provided by:
Universitätsklinikum Ulm
Article History
First Online: 5 February 2020
Compliance with Ethical Standards
:
: Annika Scheffold declares that she has no conflict of interest.Stephan Stilgenbauer has received fees for consulting, drug/equipment supplied by the entity, travel paid by the entity, and provided writing assistance for AbbVie, AstraZeneca, Celgene, Gilead, GlaxoSmithKline, Hoffmann-La Roche, Janssen, Novartis, Pharmacyclics, and Sunesis Pharmaceuticals.
: This article contains studies with human subjects which has been published by the authors.